{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:48:14Z","timestamp":1792601294434,"version":"4.5.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.pain.2007.06.026","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T07:08:24Z","timestamp":1187334504000},"page":"154-168","source":"Crossref","is-referenced-by-count":104,"title":["Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer"],"prefix":"10.1097","volume":"132","author":[{"given":"Tamara","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vardanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Majuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohannes","family":"Melemedjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Nagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Cress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Vanderah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210227","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bmj.322.7295.1154","article-title":"Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.","volume":"322","author":"Allan","year":"2001","journal-title":"BMJ"},{"key":"R2-23-20210227","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00210-005-0013-6","article-title":"Effects of the local administration of selective mu-, delta- and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia.","volume":"372","author":"Baamonde","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R3-23-20210227","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bone.2006.06.004","article-title":"Osteoclast formation and bone resorption are inhibited by megakaryocytes.","volume":"39","author":"Beeton","year":"2006","journal-title":"Bone"},{"key":"R4-23-20210227","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbrc.2004.11.077","article-title":"Osteoclast signalling pathways.","volume":"328","author":"Blair","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-23-20210227","first-page":"83","article-title":"Recent advances in bone biology provide insight into the pathogenesis of bone diseases.","volume":"79","author":"Boyce","year":"1999","journal-title":"Lab Invest"},{"key":"R8-23-20210227","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00000542-200603000-00023","article-title":"Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase.","volume":"104","author":"Celerier","year":"2006","journal-title":"Anesthesiology"},{"key":"R9-23-20210227","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw.","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"R10-23-20210227","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpain.2005.08.001","article-title":"Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.","volume":"7","author":"Chu","year":"2006","journal-title":"J Pain"},{"key":"R11-23-20210227","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/cncr.11144","article-title":"Bone cancer pain.","volume":"97","author":"Clohisy","year":"2003","journal-title":"Cancer"},{"key":"R12-23-20210227","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jor.1100140103","article-title":"Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts.","volume":"14","author":"Clohisy","year":"1996","journal-title":"J Orthop Res"},{"key":"R13-23-20210227","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jor.1100130613","article-title":"Tumor osteolysis in osteopetrotic mice.","volume":"13","author":"Clohisy","year":"1995","journal-title":"J Orthop Res"},{"key":"R14-23-20210227","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0736-0266(02)00133-X","article-title":"RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis.","volume":"21","author":"Clohisy","year":"2003","journal-title":"J Orthop Res"},{"key":"R15-23-20210227","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy.","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"R16-23-20210227","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies.","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"R17-23-20210227","first-page":"251","article-title":"A simple murine model for immobilization osteopenia.","volume":"244-","author":"Damrongrungruang","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"R18-23-20210227","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0885-3924(91)90005-O","article-title":"Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction.","volume":"6","author":"De Conno","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"R19-23-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations.","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R20-23-20210227","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10555-006-9021-3","article-title":"The RANKRANKLOPG triad in cancer-induced bone diseases.","volume":"25","author":"Dougall","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"R21-23-20210227","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2006.01.048","article-title":"Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.","volume":"534","author":"Feng","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R22-23-20210227","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2005.11.009","article-title":"Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery.","volume":"396","author":"Gardell","year":"2006","journal-title":"Neurosci Lett"},{"key":"R23-23-20210227","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1523\/JNEUROSCI.22-15-06747.2002","article-title":"Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.","volume":"22","author":"Gardell","year":"2002","journal-title":"J Neurosci"},{"key":"R24-23-20210227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00007256-200232070-00005","article-title":"Skeletal adaptations to alterations in weight-bearing activity: a comparison of models of disuse osteoporosis.","volume":"32","author":"Giangregorio","year":"2002","journal-title":"Sports Med"},{"key":"R25-23-20210227","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"key":"R26-23-20210227","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/jbmr.1999.14.3.464","article-title":"Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.","volume":"14","author":"Halleen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"R27-23-20210227","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations.","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"R28-23-20210227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","article-title":"Controlled-release oxycodone and morphine in cancer related pain.","volume":"73","author":"Heiskanen","year":"1997","journal-title":"Pain"},{"key":"R29-23-20210227","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.","volume":"6","author":"Honore","year":"2000","journal-title":"Nat Med"},{"key":"R30-23-20210227","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0306-4522(00)00110-X","article-title":"Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.","volume":"98","author":"Honore","year":"2000","journal-title":"Neuroscience"},{"key":"R31-23-20210227","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1248\/bpb.16.762","article-title":"Enhancement of tumor growth by morphine and its possible mechanism in mice.","volume":"16","author":"Ishikawa","year":"1993","journal-title":"Biol Pharm Bull"},{"key":"R32-23-20210227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0765.2005.00868.x","article-title":"Mechanisms involved in the enhancement of osteoclast formation by enamel matrix derivative.","volume":"41","author":"Itoh","year":"2006","journal-title":"J Periodontal Res"},{"key":"R33-23-20210227","first-page":"3307","article-title":"Morphine-induced hyperalgesia, allodynia and myoclonus - new side-effects of morphine?.","volume":"157","author":"Jacobsen","year":"1995","journal-title":"Ugeskr Laeger"},{"key":"R34-23-20210227","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1523\/JNEUROSCI.1850-04.2004","article-title":"A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine.","volume":"24","author":"Johnston","year":"2004","journal-title":"J Neurosci"},{"key":"R35-23-20210227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2005.11.054","article-title":"Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.","volume":"1070","author":"Juni","year":"2006","journal-title":"Brain Res"},{"key":"R36-23-20210227","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0091-3057(02)00908-5","article-title":"Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains.","volume":"73","author":"Kest","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R37-23-20210227","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pain.2005.04.014","article-title":"Role of NK-1 neurotransmission in opioid-induced hyperalgesia.","volume":"116","author":"King","year":"2005","journal-title":"Pain"},{"key":"R38-23-20210227","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000087658","article-title":"Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?","volume":"14","author":"King","year":"2005","journal-title":"Neurosignals"},{"key":"R39-23-20210227","first-page":"2655","article-title":"Genetic variation - important for the clinical effect of opioids?.","volume":"125","author":"Klepstad","year":"2005","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R40-23-20210227","doi-asserted-by":"crossref","first-page":"30192","DOI":"10.1074\/jbc.M504179200","article-title":"Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system.","volume":"280","author":"Kondo","year":"2005","journal-title":"J Biol Chem"},{"key":"R41-23-20210227","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0306-4522(98)00652-6","article-title":"Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity.","volume":"89","author":"Laulin","year":"1999","journal-title":"Neuroscience"},{"key":"R42-23-20210227","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1046\/j.1460-9568.1998.00083.x","article-title":"Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time.","volume":"10","author":"Laulin","year":"1998","journal-title":"Eur J Neurosci"},{"key":"R44-23-20210227","first-page":"4038","article-title":"Osteoprotegerin diminishes advanced bone cancer pain.","volume":"61","author":"Luger","year":"2001","journal-title":"Cancer Res"},{"key":"R45-23-20210227","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0304-3959(02)00102-1","article-title":"Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain.","volume":"99","author":"Luger","year":"2002","journal-title":"Pain"},{"key":"R46-23-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00226-8","article-title":"Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons.","volume":"99","author":"Ma","year":"2000","journal-title":"Neuroscience"},{"key":"R47-23-20210227","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.87.9.3294","article-title":"Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines.","volume":"87","author":"Maneckjee","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"R48-23-20210227","first-page":"1033","article-title":"Opioids induce while nicotine suppresses apoptosis in human lung cancer cells.","volume":"5","author":"Maneckjee","year":"1994","journal-title":"Cell Growth Differ"},{"key":"R49-23-20210227","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(03)02284-4","article-title":"Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain.","volume":"969","author":"Menendez","year":"2003","journal-title":"Brain Res"},{"key":"R50-23-20210227","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00001756-200305060-00018","article-title":"Peripheral opioids act as analgesics in bone cancer pain in mice.","volume":"14","author":"Menendez","year":"2003","journal-title":"Neuroreport"},{"key":"R51-23-20210227","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pbb.2005.02.007","article-title":"Analgesic effects of loperamide in bone cancer pain in mice.","volume":"81","author":"Menendez","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"R52-23-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3959(91)90172-T","article-title":"What is the definition of breakthrough pain?","volume":"45","author":"Mercadante","year":"1991","journal-title":"Pain"},{"key":"R53-23-20210227","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0959-8049(97)10053-3","article-title":"Predictive factors and opioid responsiveness in cancer pain.","volume":"34","author":"Mercadante","year":"1998","journal-title":"Eur J Cancer"},{"key":"R54-23-20210227","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","article-title":"Opioid rotation for cancer pain: rationale and clinical aspects.","volume":"86","author":"Mercadante","year":"1999","journal-title":"Cancer"},{"key":"R55-23-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(98)00118-3","article-title":"Problems of long-term spinal opioid treatment in advanced cancer patients.","volume":"79","author":"Mercadante","year":"1999","journal-title":"Pain"},{"key":"R56-23-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpainsymman.2005.04.014","article-title":"Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.","volume":"30","author":"Mercadante","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R57-23-20210227","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","article-title":"Hyperalgesia: an emerging iatrogenic syndrome.","volume":"26","author":"Mercadante","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R58-23-20210227","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/annonc\/mdi922","article-title":"World Health Organization guidelines for cancer pain: a reappraisal.","volume":"16","author":"Mercadante","year":"2005","journal-title":"Ann Oncol"},{"key":"R59-23-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0885-3924(00)00236-0","article-title":"Opioid poorly-responsive cancer pain. part 2: basic mechanisms that could shift dose response for analgesia.","volume":"21","author":"Mercadante","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"R60-23-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jmg.2004.027698","article-title":"Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans.","volume":"42","author":"Mogil","year":"2005","journal-title":"J Med Genet"},{"key":"R61-23-20210227","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/neu.20091","article-title":"Antinociceptive and nociceptive actions of opioids.","volume":"61","author":"Ossipov","year":"2004","journal-title":"J Neurobiol"},{"key":"R62-23-20210227","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.expneurol.2004.11.028","article-title":"Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.","volume":"193","author":"Peters","year":"2005","journal-title":"Exp Neurol"},{"key":"R63-23-20210227","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.09.007","article-title":"Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects.","volume":"82","author":"Pud","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R64-23-20210227","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/j.biomaterials.2006.04.004","article-title":"Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo.","volume":"27","author":"Ren","year":"2006","journal-title":"Biomaterials"},{"key":"R65-23-20210227","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2165\/00003495-200161070-00005","article-title":"Strategies for the treatment of cancer pain in the new millennium.","volume":"61","author":"Ripamonti","year":"2001","journal-title":"Drugs"},{"key":"R66-23-20210227","first-page":"7343","article-title":"Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.","volume":"62","author":"Sabino","year":"2002","journal-title":"Cancer Res"},{"key":"R67-23-20210227","first-page":"561","article-title":"The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain.","volume":"2","author":"Sabino","year":"2002","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"R68-23-20210227","first-page":"106","article-title":"Experimental evidence for immunomodulatory effects of opioids.","volume":"521","author":"Sacerdote","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"R69-23-20210227","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","article-title":"Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.","volume":"19","author":"Schwei","year":"1999","journal-title":"J Neurosci"},{"key":"R70-23-20210227","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","article-title":"Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization.","volume":"115","author":"Sevcik","year":"2005","journal-title":"Pain"},{"key":"R71-23-20210227","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0361-9230(86)90057-2","article-title":"Morphine increases metastatic tumor growth.","volume":"16","author":"Simon","year":"1986","journal-title":"Brain Res Bull"},{"key":"R72-23-20210227","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","article-title":"Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists.","volume":"59","author":"Sjogren","year":"1994","journal-title":"Pain"},{"key":"R73-23-20210227","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(93)90188-U","article-title":"Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine.","volume":"55","author":"Sjogren","year":"1993","journal-title":"Pain"},{"key":"R74-23-20210227","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2003.12.007","article-title":"Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia.","volume":"361","author":"Sommer","year":"2004","journal-title":"Neurosci Lett"},{"key":"R75-23-20210227","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1006\/bbrc.1998.9695","article-title":"Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation.","volume":"252","author":"Sueoka","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R76-23-20210227","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/carcin\/17.11.2337","article-title":"Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression.","volume":"17","author":"Sueoka","year":"1996","journal-title":"Carcinogenesis"},{"key":"R77-23-20210227","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.joca.2006.08.001","article-title":"Induction of osteoclast-like cells derived from the synovial lavage fluids of patients with temporomandibular joint disorders.","volume":"15","author":"Takano","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"R78-23-20210227","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/rheumatology\/keh077","article-title":"Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients.","volume":"43","author":"Takano","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R79-23-20210227","first-page":"1846","article-title":"G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation.","volume":"63","author":"Tegeder","year":"2003","journal-title":"Cancer Res"},{"key":"R80-23-20210227","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jpain.2005.08.005","article-title":"Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology.","volume":"6","author":"Urch","year":"2005","journal-title":"J Pain"},{"key":"R81-23-20210227","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.","volume":"20","author":"Vanderah","year":"2000","journal-title":"J Neurosci"},{"key":"R82-23-20210227","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1523\/JNEUROSCI.21-01-00279.2001","article-title":"Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance.","volume":"21","author":"Vanderah","year":"2001","journal-title":"J Neurosci"},{"key":"R83-23-20210227","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jor.20010","article-title":"Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP-2 alone or together with rhVEGF.","volume":"24","author":"Wan","year":"2006","journal-title":"J Orthop Res"},{"key":"R84-23-20210227","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2299::AID-CNCR1>3.0.CO;2-O","article-title":"Controlled-release morphine tablets in patients with chronic cancer pain.","volume":"82","author":"Warfield","year":"1998","journal-title":"Cancer"},{"key":"R85-23-20210227","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis.","volume":"115","author":"Wei","year":"2005","journal-title":"J Clin Invest"},{"key":"R87-23-20210227","first-page":"344","article-title":"Opioids alter tumor cell growth and differentiation in vitro.","volume":"49","author":"Zagon","year":"1984","journal-title":"NIDA Res Monogr"},{"key":"R88-23-20210227","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.npep.2005.07.001","article-title":"Opioids and differentiation in human cancer cells.","volume":"39","author":"Zagon","year":"2005","journal-title":"Neuropeptides"},{"key":"R89-23-20210227","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00001813-199504003-00008","article-title":"Transdermal fentanyl in combination with initial intravenous dose titration by patient-controlled analgesia.","volume":"6","author":"Zech","year":"1995","journal-title":"Anticancer Drugs"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006396-200711000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T18:46:32Z","timestamp":1617907592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006396-200711000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2007.06.026","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}